You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,537,585


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,537,585 protect, and when does it expire?

Patent 10,537,585 protects HEMADY and is included in one NDA.

This patent has one patent family member in one country.

Summary for Patent: 10,537,585
Patent landscape, scope, and claims:
Title:Compositions comprising dexamethasone
Abstract: A pharmaceutical composition useful for the treatment of multiple myeloma in combination with an anti-cancer drug is provided. The pharmaceutical composition includes high-dose dexamethasone or a pharmaceutically acceptable salt or solvate thereof.
Inventor(s): Kreyenborg; Caterina (Munster, DE), Meimberg; Elisabeth (Emsdetten, DE), Tissen; Corinna (Senden, DE), Bannefeld; Karl-Heinz (Munster, DE), Gold; Tomer (Herzliya, IL)
Assignee: DEXCEL PHARMA TECHNOLOGIES LTD. (Or-Akiva, IL)
Application Number:15/845,232
Patent Claim Types:
see list of patent claims
Compound; Dosage form;

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,537,585

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Dexcel HEMADY dexamethasone TABLET;ORAL 211379-001 Oct 3, 2019 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,537,585

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
World Intellectual Property Organization (WIPO) 2019123453 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.